Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 2181–2200 of 17,529 recalls

April 26, 2023· Akorn, Inc.

Recalled Item: Ropivacaine Hydrochloride Injection USP

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Atropine Sulfate Ophthalmic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: AK-POLY-BAC (bacitracin Zinc and Polymyxin B Sulfate) Ophthalmic Ointment

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Lorazepam Injection

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Naloxone Injection

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Cromolyn Sodium Ophthalmic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: IC-Green (indocyanine green for injection

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Amantadine Hydrochloride Oral Solution USP

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Pilocarpine Hydrochloride Ophthalmic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Levofloxacin Oral Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Dicyclomine Hydrochloride Injection USP

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Diuril (chlorothiazide sodium) Injection

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Fentanyl Citrate Injection

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Prednisolone Oral Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Valproic Acid Oral Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Tobramycin Inhalation Solution USP

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Tobramycin Ophthalmic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Guaifenesin Oral Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Apraclonidine Ophthalmic Solution 0.5%

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Acetaminophen & Codeine Phosphate Oral Solution 120mg/12mg/5mL

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund